Lyra Therapeutics, Inc.

Insmed Incorporated , Structure Therapeutics, Inc. and Merus N.V. raised more than $1.5bn combined in recent follow-on public offerings (FOPOs), taking advantage of a spike in investor interest an

Initial public offerings in the US are in a slump, with just nine biopharmaceutical company IPOs during the first quarter, raising a total of $807m. The Q1 tally is a fraction of the offerings and the

Heartseed Gets $55m Up Front Japanese bioventure Heartseed Inc. and Novo Nordisk A/S announced a worldwide collaboration and license agreement on 1 June for the development, manufacture and commer